Quick Answer
Replimune Group, Inc. reported Operating Income Loss of -$261.63 million for the year ending 2025.
- Replimune Group, Inc. showed a decrease of -11.4% in Operating Income Loss from 2024 to 2025.
- This data is from Replimune Group, Inc.'s annual report (Form 10-K), filed with the SEC on May 22, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: -$3.18 million | Q3 2017: -$4.26 million | Q4 2017: -$4.73 million | Q2 2018: -$5.88 million | Q3 2018: -$7.10 million | Q4 2018: -$10.14 million | Q2 2019: -$10.91 million | Q3 2019: -$12.24 million | Q4 2019: -$16.66 million | Q2 2020: -$17.83 million | Q3 2020: -$19.66 million | Q4 2020: -$20.28 million | Q2 2021: -$27.38 million | Q3 2021: -$29.25 million | Q4 2021: -$29.70 million | Q2 2022: -$40.88 million | Q3 2022: -$41.58 million | Q4 2022: -$41.63 million | Q2 2023: -$55.65 million | Q3 2023: -$63.83 million | Q4 2023: -$56.54 million | Q2 2024: -$57.37 million | Q3 2024: -$58.92 million | Q4 2024: -$66.02 million | Q2 2025: -$90.42 million | Q3 2025: -$84.29 million | Q4 2025: -$71.87 million.
- Over the full 9 years of available data (2017 to 2025), Replimune Group, Inc.'s Operating Income Loss has declined by 2,612.0%.
- Historical annual values: Fiscal year 2025: -$261.63 million | Fiscal year 2024: -$234.77 million | Fiscal year 2023: -$177.08 million | Fiscal year 2022: -$118.31 million | Fiscal year 2021: -$79.96 million | Fiscal year 2020: -$56.20 million | Fiscal year 2019: -$30.95 million | Fiscal year 2018: -$19.23 million | Fiscal year 2017: -$9.65 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: